Effects of intermittent exercise on biomarkers of cardiovascular risk in night shift workers

Atherosclerosis

Volumn 242, Issue 1, 2015, Pages 186-190

  Lim, Seung Taek ^a   Min, Seok Ki ^b   Kwon, Yoo Chan ^a   Park, Sang Kab ^a   Park, Hyuntae ^a,c  

^a Dong A University   (South Korea)

^b Korea Institute of Sport Science   (South Korea)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Adhesion molecules; Cathepsin K; Cathepsin L; Cathepsin S; Intermittent exercise; Night shift worker

Indexed keywords

CATHEPSIN L; CATHEPSIN S; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SOLUBLE E SELECTIN; SOLUBLE VASCULAR CELL ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; CATHEPSIN; CELL ADHESION MOLECULE; CTSL1 PROTEIN, HUMAN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EXERCISE; HUMAN; INTERMITTENT EXERCISE; MALE; NIGHT SHIFT WORKER; NIGHT WORK; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHIFT WORKER; BLOOD; CARDIOVASCULAR DISEASES; KINESIOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PERSONNEL MANAGEMENT; PROCEDURES; PROTECTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SOUTH KOREA; TIME FACTOR;

BIOMARKERS; BLOOD PRESSURE; BODY COMPOSITION; CARDIOVASCULAR DISEASES; CATHEPSIN L; CATHEPSINS; CELL ADHESION MOLECULES; EXERCISE THERAPY; HUMANS; MALE; MIDDLE AGED; PERSONNEL STAFFING AND SCHEDULING; PROTECTIVE FACTORS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84937203661     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.06.017     Document Type: Article

References (36)

1. Pimenta A.M., Kac G., Souza R.R., Ferreira L.M., Silqueira S.M. Night-shift work and cardiovascular risk among employees of a public university. Rev. Assoc. Med. Bras. 2012, 58(2):168-177.
2. Mosendane T., Mosendane T., Raal F.J. Shift work and its effects on the cardiovascular system. Cardiovasc J. Afr. 2008, 19(4):210-215.
3. Cheng X.W., Kikuchi R., Ishii H., et al. Circulating cathepsin K as a potential novel biomarker of coronary artery disease. Atherosclerosis 2013, 228(1):211-216.
4. Turk V., Turk B., Guncar G., Turk D., Kos J. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv. Enzyme Regul. 2002, 42:285-303.
5. Qin Y., Shi G.P. Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. Pharmacol. Ther. 2011, 131(3):338-350.
6. Li X., Liu Z., Cheng Z., Cheng X. Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease. Chonnam Med. J. 2012, 48(2):77-85.
7. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol. 2001, 88(8):10-15.
8. Libby P. Inflammation in atherosclerosis. Nature 2002, 26(420):868-874.
9. Murphy M.H., Blair S.N., Murtagh E.M. Accumulated versus continuous exercise for health benefit: a review of empirical studies. Sports Med. 2009, 39(1):29-43.
10. Wehrens S.M., Hampton S.M., Skene D.J. Heart rate variability and endothelial function after sleep deprivation and recovery sleep among male shift and non-shift workers. Scand. J. Work Environ. Health 2012, 38(2):171-181.
11. L.S. Pescatellos, D. Riebe, R. Arena, American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Presription, ninth ed. Baltimore: Lippincott Williams & Wiklkins, 2014.
12. Pimenta A.M., Kac G., Souza R.R. Night-shift work and cardiovascular risk among employees of a public university. Rev. Assoc. Med. Bras. 2012, 58(2):168-177.
13. Harrington J.M. Health effects of shift work and extended hours of work. Ann. Acad. Med. Singap. 1994, 23(5):699-705.
14. Waterhouse J., Folkard S., Minors D. Shift Work, Health and Safety. An Overview of the Scientific Literature 1978-1990 1992, HMSO, London, HSE contract research report. 1992.
15. Vyas M.V., Garg A.X., Iansavichus A.V., et al. Shift work and vascular events: systematic review and meta-analysis. BMJ 2012, 345:e4800.
16. Lv B.J., Lindholt J.S., Wang J., Cheng X., Shi G.P. Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study. Atherosclerosis 2013, 230(1):100-105.
17. Sun M., Ouzounian M., de Couto G., et al. Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways. J. Am. Heart Assoc. 2013, 2(2):1-18.
18. Liu Y., Li X., Peng D. Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease. Am. J. Cardiol. 2009, 103(4):476-481.
19. Jobs E., Ingelsson E., Risérus U. Association between serum cathepsin S and mortality in older adults. JAMA 2011, 306(10):1113-1121.
20. Liu Y., Li X., Peng D., et al. Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease. Am. J. Cardiol. 2009, 103(4):476-481.
21. Taleb S., Cancello R., Poitou C., et al. Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women. J. Clin. Endocrinol. Metab. 2006, 91(3):1042-1047.
22. Cheng X.W., Shi G.P., Kuzuya M., Sasaki T., Okumura K., Murohara T. Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication. Circulation 2012, 125(12):1551-1562.
23. Ota T. Chemokine systems link obesity to insulin resistance. Diabetes Metab. J. 2013, 37(3):165-172.
24. Eirin A., Gloviczki M.L., Tang H., et al. Inflammatory and injury signals released from the post-stenotic human kidney. Eur. Heart J. 2013, 34(7):540-548a.
25. Albelda S.M., Smith C.W., Ward P.A. Adhesion molecules and inflammatory injury. FASEB J. 1994, 8(8):504-512.
26. Trøseid M., Lappegård K.T., Mollnes T.E., Arnesen H., Seljeflot I. Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome. Scand. J. Clin. Lab. Invest 2005, 65(4):283-290.
27. Oh E.G., Bang S.Y., Kim S.H., et al. Therapeutic lifestyle modification program reduces plasma levels of the chemokines CRP and MCP-1 in subjects with metabolic syndrome. Biol. Res. Nurs. 2013, 15(1):48-55.
28. Fuentes Y., Hernández A.M., García-Roca P., et al. Urinary MCP-1/creatinine in Henoch-Schönlein purpura and its relationship with nephritis. Pediatr. Nephrol. 2014, 29(6):1047-1052.
29. Laucella S.A., Segura E.L., Riarte A., Sosa E.S. Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease. Clin. Exp. Immunol. 1999, 118(3):423-427.
30. Marqueze E.C., Ulhoa M.A., Castro Moreno C.R. Leisure-time physical activity does not fully explain the higher body mass index in irregular-shift workers. Int. Arch. Occup. Environ. 2014, 87(3):229-239.
31. Karstoft K., Winding K., Knudsen S.H., et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2012, 36(2):228-236.
32. Costa G. The impact of shift and night work on health. Appl. Ergon. 1996, 27(1):9-16.
33. Danielsen K.K., Svendsen M., Mæhlum S., Sundgot-Borgen J. Changes in body composition, cardiovascular disease risk factors, and eating behavior after an intensive lifestyle intervention with high volume of physical activity in severely obese subjects: a prospective clinical controlled trial. J. Obes. 2013, 325464. 10.1155/2013/325464.
34. Ford P.A., Perkins G., Swaine I. Effects of a 15-week accumulated brisk walking programme on the body composition of primary school children. J. Sports Sci. 2013, 31(2):114-122.
35. Murphy M.H., Hardman A.E. Training effects of short and long bouts of brisk walking in sedentary women. Med. Sci. Sports Exerc. 1998, 30(1):152-157.
36. Park H., Park S., Shephard R.J., Aoyagi Y. Yearlong physical activity and sarcopenia in older adults: the Nakanojo Study. Eur. J. Appl. Physiol. 2010, 109(5):953-961.